Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups.

Rawlings, M Keith; Letang, Emilio; Quercia, Romina; Grove, Richard; DeMasi, Ralph; Min, Sherene; Vannappagari, Vani; Zolopa, Andrew; van Wyk, Jean; Smith, Kimberly

Rawlings, M Keith; Letang, Emilio; Quercia, Romina; Grove, Richard; DeMasi, Ralph; Min, Sherene; Vannappagari, Vani; Zolopa, Andrew; van Wyk, Jean; Smith, Kimberly.

Afiliación

Rawlings MK; ViiV Healthcare, Durham, North Carolina, USA.
Letang E; ViiV Healthcare, Madrid, Spain.
Quercia R; ViiV Healthcare, Brentford, UK.
Grove R; GSK, Brentford, UK.
DeMasi R; ViiV Healthcare, Durham, North Carolina, USA.
Min S; ViiV Healthcare, Durham, North Carolina, USA.
Vannappagari V; ViiV Healthcare, Durham, North Carolina, USA.
Zolopa A; ViiV Healthcare, Durham, North Carolina, USA.
van Wyk J; Stanford University, Palo Alto, California, USA.
Smith K; ViiV Healthcare, Brentford, UK.

Open Forum Infect Dis ; 9(8): ofac304, 2022 Aug.

Article en En | MEDLINE | ID: mdl-36046700

Palabras clave

demographics; dolutegravir; integrase strand transfer inhibitor; pooled analysis; regional analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Determinantes_sociais_saude Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google